✦ LIBER ✦

Malignant melanoma; a correlation between histological features and tumour-directed cell-mediated immunity

✍ Scribed by Rona M. MacKie; A.J. Cochran; R.M. Grant; C.E. Ross; D.E. Hoyle

Book ID: 108654207
Publisher: John Wiley and Sons
Year: 1974
Tongue: English
Weight: 66 KB
Volume: 91
Category: Article
ISSN: 0007-0963
DOI: 10.1111/j.1365-2133.1974.tb12490.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sequential studies on cell-mediated tumo

Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma

✍ I. Hellström; G. A. Warner; K. E. Hellström; H. O. Sjögren 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 French ⚖ 920 KB

## Abstract Ten human patients with malignant melanoma were followed with respect to two __in vitro__ parameters of tumor immunity, the ability of the patients' blood lymphocytes to destroy cultivated melanoma cells, and the ability of the patients' sera to block such destruction, and with respect

A lung colony clonogenic cell assay for

A lung colony clonogenic cell assay for human malignant melanoma in immune-suppressed mice and its use to determine chemosensitivity, radiosensitivity and the relationship between tumour size and response to therapy

✍ J. Meirion Thomas 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 450 KB

Lack of correlation between peripheral b

Lack of correlation between peripheral blood lymphokine-activated killer (lak) cell function and clinical response in patients with advanced malignant melanoma receiving recombinant interleukin 2

✍ A. K. Ghosh; H. Dazzi; N. Thatcher; M. Moore 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 634 KB

A phase-1/11 study of recombinant interleukin 2 (rll-2) was performed in 31 melanoma patients. The first dose of rlL-2 was given intrasplenically followed 4 hr later by an i.v. dose and 3 further i.v. doses on alternate days. Three courses of treatment were planned at 3-week intervals. The maximum t